Duchenne-like myopathy in double-mutant mdx mice expressing exaggerated mast cell activity
- PMID: 7561939
- DOI: 10.1016/0022-510x(95)00089-k
Duchenne-like myopathy in double-mutant mdx mice expressing exaggerated mast cell activity
Abstract
Dystrophin-deficient female mdx mice were bred with male Tsk+/+ pa mice to examine the role played by mast cells in the pathophysiology of dystrophin deficiency. Resultant mdx/Tsk double-mutant mice were then examined functionally, biochemically, and histologically. While mdx mice remained as strong as their normal counterparts, mdx/Tsk double-mutant mice became progressively weak with age. Serum creatine kinase activity was significantly elevated in both mdx and mdx/Tsk double-mutant mice over normal controls. However, mast cell-derived plasma tryptase activity was consistently higher in the double-mutant than in mdx mice. In addition, histological examination of gastrocnemius muscle revealed that while necrosis was persistent in both strains of mdx mice from 2 to 8 weeks of age, regeneration was significantly reduced in the double-mutant mice. Of particular interest was the fact that necrosis in the mdx/Tsk double mutant exceeded mdx values at 8 weeks of age, corresponding approximately with a second peak in tryptase activity. Therefore, heightened mast cell activity appears to elicit in the dystrophin-deficient mdx mouse a myopathy not unlike the human Duchenne disease.
Similar articles
-
Enhanced sensitivity of mdx mice to intramuscular injection of compound 48/80.Res Commun Chem Pathol Pharmacol. 1994 Jun;84(3):351-62. Res Commun Chem Pathol Pharmacol. 1994. PMID: 7938907
-
Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice.Neuromuscul Disord. 1998 Dec;8(8):542-50. doi: 10.1016/s0960-8966(98)00078-9. Neuromuscul Disord. 1998. PMID: 10093060
-
Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles.Anat Rec. 1998 Oct;252(2):311-24. doi: 10.1002/(SICI)1097-0185(199810)252:2<311::AID-AR17>3.0.CO;2-Q. Anat Rec. 1998. PMID: 9776086
-
A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice.J Neurol Sci. 1994 Mar;122(1):44-56. doi: 10.1016/0022-510x(94)90050-7. J Neurol Sci. 1994. PMID: 8195802
-
How does dystrophin deficiency lead to muscle degeneration?--evidence from the mdx mouse.Neuromuscul Disord. 1995 Nov;5(6):445-56. doi: 10.1016/0960-8966(95)00001-4. Neuromuscul Disord. 1995. PMID: 8580726 Review.
Cited by
-
Immune-mediated pathology in Duchenne muscular dystrophy.Sci Transl Med. 2015 Aug 5;7(299):299rv4. doi: 10.1126/scitranslmed.aaa7322. Sci Transl Med. 2015. PMID: 26246170 Free PMC article. Review.
-
The Immune System in Duchenne Muscular Dystrophy Pathogenesis.Biomedicines. 2021 Oct 11;9(10):1447. doi: 10.3390/biomedicines9101447. Biomedicines. 2021. PMID: 34680564 Free PMC article. Review.
-
Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-κB Signaling Pathway.J Biol Chem. 2015 Jul 17;290(29):17784-17795. doi: 10.1074/jbc.M115.655019. Epub 2015 May 26. J Biol Chem. 2015. Retraction in: J Biol Chem. 2023 Dec;299(12):105434. doi: 10.1016/j.jbc.2023.105434. PMID: 26013831 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases